arrow
J

Janet Dawson

Novartis
H指数:30
被引数:3,003

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement
2025-10-010
PRE
A cereblon-based glue degrader of NEK7 regulates NLRP3 inflammasome in a context-dependent manner

cereblon基 glue降解剂通过NEK7以依赖背景的方式调控NLRP3炎症小体

2025-07-090
PRE
Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors

发现有效的口服生物可利用的三环NLRP3抑制剂

2024-01-0414
PRE
Nonhematopoietic IRAK1 drives arthritis via chemoattractants
2022-07-083
OA
Discovery of LYS006, a Potent and Highly Selective Inhibitor of Leukotriene A4 Hydrolase
2021-02-1624
PREAI
Structure-Based and Property-Driven Optimization of N-Aryl Imidazoles toward Potent and Selective Oral RORγt Inhibitors
2019-11-1514
PREAI
Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitors
2017-10-1931
OAAI
A natural ligand for the orphan receptor GPR15 modulates lymphocyte recruitment to epithelia
2017-09-1275
PREAI
Design and synthesis of potent and orally active GPR4 antagonists with modulatory effects on nociception, inflammation, and angiogenesis

对伤害感受,炎症和血管生成具有调节作用的有效和口服活性的GPR4拮抗剂的设计和合成

2017-08-0122
PREAI
Deficiency of MALT1 Paracaspase Activity Results in Unbalanced Regulatory and Effector T and B Cell Responses Leading to Multiorgan Inflammation
2015-04-15116
OAAI